A risk scale for predicting extensive subclinical spread of nonmelanoma skin cancer
- PMID: 11860418
- DOI: 10.1046/j.1524-4725.2002.02902.x
A risk scale for predicting extensive subclinical spread of nonmelanoma skin cancer
Abstract
Background: The clinical appearance of nonmelanoma skin cancer may represent only a portion of microscopic tumor invasion.
Objective: To develop a scale based on high-risk characteristics for predicting the probability of extensive subclinical spread of nonmelanoma skin cancer.
Methods: Retrospective analysis of 1095 Mohs micrographic surgical cases (MMS) yielded high-risk factors for extensive tumor spread, defined as requirement of greater-than-or-equal3 MMS layers. Predictive characteristics included: any BCC on the nose, morpheaform BCC on the cheek, neck tumors and recurrent BCC in men, location on the eyelid, temple, or ear helix, and size>10 mm. Multivariate logistic regression was applied to develop a risk index.
Results: Tumor characteristics were assigned point values calculated from the respective odds of extension and categorized into six risk classes with probabilities of extensive subclinical spread ranging from 10% to 56%.
Conclusion: A risk scale simplifies and enhances prediction of extensive tumors. The associated probabilities can help to guide patient preparation and appropriate therapy.
Similar articles
-
Predictors of extensive subclinical spread in nonmelanoma skin cancer treated with Mohs micrographic surgery.Arch Dermatol. 2002 Aug;138(8):1043-51. doi: 10.1001/archderm.138.8.1043. Arch Dermatol. 2002. PMID: 12164742
-
Demographic and Tumor Characteristics of Patients Younger Than 50 Years With Nonmelanoma Skin Cancer Referred for Mohs Micrographic Surgery.J Drugs Dermatol. 2018 May 1;17(5):499-505. J Drugs Dermatol. 2018. PMID: 29742179
-
Mohs micrographic surgery for basal cell carcinomas: appropriateness of 'Rotterdam' criteria and predictive factors for three or more stages.J Eur Acad Dermatol Venereol. 2013 Oct;27(10):1228-35. doi: 10.1111/j.1468-3083.2012.04696.x. Epub 2012 Oct 8. J Eur Acad Dermatol Venereol. 2013. PMID: 23039378
-
Surgical margins in the treatment of nonmelanoma skin cancer and mohs micrographic surgery.Curr Surg. 2005 Sep-Oct;62(5):518-26. doi: 10.1016/j.cursur.2005.01.003. Curr Surg. 2005. PMID: 16125611 Review.
-
Mohs' micrographic surgery for treatment of basal cell carcinoma of the face--results of a retrospective study and review of the literature.Br J Dermatol. 2004 Jul;151(1):141-7. doi: 10.1111/j.1365-2133.2004.06047.x. Br J Dermatol. 2004. PMID: 15270883 Review.
Cited by
-
Head and neck cutaneous basal cell carcinoma: what should the otorhinolaryngology head and neck surgeon care about?Acta Otorhinolaryngol Ital. 2020 Feb;40(1):5-18. doi: 10.14639/0392-100X-2245. Epub 2019 Jul 31. Acta Otorhinolaryngol Ital. 2020. PMID: 31388193 Free PMC article. Review.
-
Differences in actin expression between primary and recurrent facial basal cell carcinomas as a prognostic factor of local recurrence.Postepy Dermatol Alergol. 2021 Jun;38(3):490-497. doi: 10.5114/ada.2021.107935. Epub 2021 Jul 26. Postepy Dermatol Alergol. 2021. PMID: 34377133 Free PMC article.
-
Teledermatology for diagnosing skin cancer in adults.Cochrane Database Syst Rev. 2018 Dec 4;12(12):CD013193. doi: 10.1002/14651858.CD013193. Cochrane Database Syst Rev. 2018. PMID: 30521686 Free PMC article.
-
Application of the AJCC 7th edition carcinoma of the eyelid staging system: a medical center pathology based, 15-year review.Clin Ophthalmol. 2011;5:1645-8. doi: 10.2147/OPTH.S26418. Epub 2011 Nov 18. Clin Ophthalmol. 2011. PMID: 22140312 Free PMC article.
-
The importance of superficial basal cell carcinoma in a retrospective study of 139 patients who underwent Mohs micrographic surgery in a Brazilian university hospital.Clinics (Sao Paulo). 2015 Nov;70(11):721-5. doi: 10.6061/clinics/2015(11)01. Clinics (Sao Paulo). 2015. PMID: 26602517 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical